Publications

SARS-CoV-2 and influenza viruses are significant public health threats with varying impacts on global health. SARS-CoV-2, the virus behind the COVID-19 pandemic, exhibits high transmissibility and recurrent waves driven by new variants.
This protocol describes the methods to estimate the Coronavirus disease 2019 (COVID-19) XBB.1.5. monovalent-adapted VE in immunocompromised persons (ICP), against COVID-19 hospitalisations and deaths.
This report by EFSA and the ECDC presents the results of zoonoses monitoring and surveillance activities carried out in 2024 in 27 Member States (MSs), the United Kingdom (Northern Ireland) and eight non- MSs, according to the Zoonoses Directive 2003/99/EC.

Featured

This interactive dashboard provides a weekly integrated epidemiological summary for influenza, RSV and SARS-CoV-2.

The Learning Portal provides training courses and materials primarily for public health professionals working in infectious diseases.

Join the ECDC Crowd and work on improving and transforming health science one task at a time with your insights on study design, statistical analysis, data collection and interpretation

About ECDC

ECDC collects, analyses and shares data on more than 50 infectious disease topics. ECDC experts assess risks to Europe and provide guidance to help countries prevent and respond to outbreaks and public health threats.

Read about ECDC